What is the treatment protocol for Sinus bradycardia?

When addressing sinus bradycardia, the primary goal is to manage the patient's symptoms and enhance the heart rate, if necessary. Administering oxygen is important if the patient displays signs of hypoxemia, but when bradycardia is causing hemodynamic instability or is symptomatic (such as dizziness, weakness, or confusion), atropine is an effective treatment option.

Atropine is an anticholinergic medication that works by blocking the action of the vagus nerve on the heart, thereby increasing the heart rate. This is particularly useful in cases of symptomatic bradycardia. In situations where the patient's condition is stable and asymptomatic, monitoring may suffice without immediate intervention. However, when symptoms are present, the combination of oxygen (to support oxygenation) and atropine (to improve heart rate) is appropriate and standard in clinical protocols.

While some might consider emergency assistance, this would typically come after initiating treatment when symptoms are not resolved, rather than being the first step. Administering anticoagulation is not indicated in the treatment of bradycardia, as it is primarily relevant for patients with thromboembolic risks, not for managing heart rate directly.